These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20358002)

  • 1. Rebamipide may be comparable to H2 receptor antagonist in healing iatrogenic gastric ulcers created by endoscopic mucosal resection: a prospective randomized pilot study.
    Kim YJ; Cheon JH; Lee SK; Kim JH; Lee YC
    J Korean Med Sci; 2010 Apr; 25(4):583-8. PubMed ID: 20358002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial.
    Ye BD; Cheon JH; Choi KD; Kim SG; Kim JS; Jung HC; Song IS
    Aliment Pharmacol Ther; 2006 Sep; 24(5):837-43. PubMed ID: 16918888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized Controlled Trial Comparing the Effects of Vonoprazan Plus Rebamipide and Esomeprazole Plus Rebamipide on Gastric Ulcer Healing Induced by Endoscopic Submucosal Dissection.
    Ichida T; Ueyama S; Eto T; Kusano F; Sakai Y
    Intern Med; 2019 Jan; 58(2):159-166. PubMed ID: 30210115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributing factors to gastric ulcer healing after endoscopic submucosal dissection including the promoting effect of rebamipide.
    Kobayashi M; Takeuchi M; Hashimoto S; Mizuno K; Sato Y; Narisawa R; Aoyagi Y
    Dig Dis Sci; 2012 Jan; 57(1):119-26. PubMed ID: 21842241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the efficacy of famotidine and rebamipide in the treatment of gastric mucosal lesions in patients receiving long-term NSAID therapy (FORCE--famotidine or rebamipide in comparison by endoscopy).
    Yamao J; Kikuchi E; Matsumoto M; Nakayama M; Ann T; Kojima H; Mitoro A; Yoshida M; Yoshikawa M; Yajima H; Miyauchi Y; Ono H; Akiyama K; Sakurai G; Kinoshita Y; Haruma K; Takakura Y; Fukui H
    J Gastroenterol; 2006 Dec; 41(12):1178-85. PubMed ID: 17287897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers.
    Takayama M; Matsui S; Kawasaki M; Asakuma Y; Sakurai T; Kashida H; Kudo M
    World J Gastroenterol; 2013 Sep; 19(34):5706-12. PubMed ID: 24039365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration.
    Yamaguchi Y; Katsumi N; Tauchi M; Toki M; Nakamura K; Aoki K; Morita Y; Miura M; Morozumi K; Ishida H; Takahashi S
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():111-5. PubMed ID: 15943857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients after eradication therapy: a randomized double-blind, multinational, multi-institutional comparative study.
    Song KH; Lee YC; Fan DM; Ge ZZ; Ji F; Chen MH; Jung HC; Bo J; Lee SW; Kim JH
    Digestion; 2011; 84(3):221-9. PubMed ID: 21757914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial.
    Terano A; Arakawa T; Sugiyama T; Suzuki H; Joh T; Yoshikawa T; Higuchi K; Haruma K; Murakami K; Kobayashi K;
    J Gastroenterol; 2007 Aug; 42(8):690-3. PubMed ID: 17701133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of lansoprazole and famotidine for gastric ulcer by endoscopic ultrasonography: a preliminary trial.
    Okai T; Sawabu N; Songür Y; Motoo Y; Watanabe H
    J Clin Gastroenterol; 1995; 20 Suppl 2():S32-5. PubMed ID: 7594335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rebamipide plus proton pump inhibitor versus proton pump inhibitor alone in the treatment of endoscopic submucosal dissection-induced gastric ulcer: a meta-analysis of randomized controlled trials.
    Xiong J; Lai S; Zhang P; Li Q; Wei Y; Yang Y; Wang T; Liu L; Ma X; Chen D
    Medicine (Baltimore); 2014 Sep; 93(12):e64. PubMed ID: 25211045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study to evaluate a new combination therapy for gastric ulcer: Helicobacter pylori eradication therapy followed by gastroprotective treatment with rebamipide.
    Terano A; Arakawa T; Sugiyama T; Yoshikawa T; Haruma K; Asaka M; Shimosegawa T; Sakaki N; Ishii H; Sakamoto C; Takahashi S; Kinoshita Y; Fujioka T; Kobayashi K
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):103-9. PubMed ID: 16706820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can rebamipide and proton pump inhibitor combination therapy promote the healing of endoscopic submucosal dissection-induced ulcers? A randomized, prospective, multicenter study.
    Shin WG; Kim SJ; Choi MH; Kim KO; Jang HJ; Park CH; Baek IH; Kim KH; Baik GH; Kae SH; Kim JH; Kim HY
    Gastrointest Endosc; 2012 Apr; 75(4):739-47. PubMed ID: 22281110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy of irsogladine maleate and famotidine for the healing of gastric ulcers after Helicobacter pylori eradication therapy: a randomized, controlled, prospective study.
    Murakami K; Okimoto T; Kodama M; Tanahashi J; Mizukami K; Shuto M; Abe H; Arita T; Fujioka T
    Scand J Gastroenterol; 2011 Mar; 46(3):287-92. PubMed ID: 21073372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
    Sakaguchi M; Ashida K; Umegaki E; Miyoshi H; Katsu K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S27-31. PubMed ID: 7594334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Multicenter, Randomized, Controlled Trial of Rebamipide Plus Lansoprazole for the Treatment of Postendoscopic Submucosal Dissection Ulcers.
    Yan B; Lu Z; Ge Z; Liu S; Guo X; Tian D; Yang Y; Li X; Gong W; Liu Z; Liu M; Zhou B; Zhao K; Pan F; Yang J; Yang Y
    Clin Transl Gastroenterol; 2019 Jan; 10(1):e00008. PubMed ID: 30702488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of rebamipide on gastric ulcer healing caused by Helicobacter pylori and/or NSAIDs or non NSAIDs-non H. pylori.
    Thong-Ngam D; Chayanupatkul M; Klaikeaw N; Rerknimitr R; Mahachai V
    J Med Assoc Thai; 2009 Sep; 92(9):1207-12. PubMed ID: 19772181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of rebamipide plus rabeprazole for the healing of artificial ulcers after endoscopic submucosal dissection.
    Fujiwara S; Morita Y; Toyonaga T; Kawakami F; Itoh T; Yoshida M; Kutsumi H; Azuma T
    J Gastroenterol; 2011 May; 46(5):595-602. PubMed ID: 21359522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ranitidine on quality of gastric ulcer healing compared with famotidine: a randomized, controlled, multicenter trial.
    Higuchi K; Watanabe T; Tominaga K; Shiba M; Nakagawa K; Uno H; Kitada K; Satoh H; Chono S; Uchida T; Fujiwara Y; Arakawa T
    Int J Clin Pharmacol Res; 2005; 25(4):187-94. PubMed ID: 16402635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Efficacy of Polaprezinc Plus Proton Pump Inhibitor and Rebamipide Plus Proton Pump Inhibitor Treatments for Endoscopic Submucosal Dissection-induced Ulcers.
    Jung DH; Park JC; Lee YC; Lee SK; Shin SK; Chung H; Park JJ; Kim JH; Youn YH; Park H
    J Clin Gastroenterol; 2021 Mar; 55(3):233-238. PubMed ID: 32341237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.